Silent myocardial ischemia in type 2 diabetic patients :: benefits of intensive treatment of cardiovascular risk factors and optimal glycemic equilibrium

被引:0
|
作者
Jacqueminet, S. [1 ]
Barthelemy, O. [2 ]
Rouzet, F. [3 ]
Isnard, R. [2 ]
Halbron, M. [1 ]
Bouzamondo, A. [4 ]
Le Guludec, D. [3 ]
Grimaldi, A. [1 ]
Metzger, J. P. [2 ]
Le Feuvre, C. [2 ]
机构
[1] Grp Hosp Pitie Salpetriere, Serv Diabetol Nutr & Malad Metab, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Inst Cardiol, F-75634 Paris, France
[3] Hop Bichat Claude Bernard, Nucl Med Serv, F-75877 Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Pharmacol, F-75634 Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P4
引用
收藏
页码:A40 / A41
页数:2
相关论文
共 50 条
  • [21] Fas/Fas-ligand and silent myocardial ischemia in type 2 diabetic patients
    Valensi, P
    Cosson, E
    Pariès, J
    Attali, JR
    Ringuer, AF
    Guillot, R
    Feldmann, G
    DIABETES, 2002, 51 : A164 - A164
  • [22] Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia -: A predictive marker
    Tarkun, I
    Cetinarstan, B
    Cantürk, Z
    Tarkun, P
    Agaçdiken, A
    Komsuoglu, B
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (03) : 165 - 168
  • [23] Homocysteine concentrations in Type 2 diabetic patients with silent myocardial ischemia: a predictive marker
    Tarkun, I
    Arslan, B
    Canturk, Z
    Tarkun, P
    Agacdiken, A
    Komsuoglu, B
    DIABETOLOGIA, 2004, 47 : A422 - A422
  • [24] Radial Pulse Spectrum Analysis as Risk Markers to Improve the Risk Stratification of Silent Myocardial Ischemia in Type 2 Diabetic Patients
    Chang, Chi-Wei
    Liao, Kuo-Meng
    Chen, Ying-Chun
    Wang, Sheng-Hung
    Jan, Ming-Yie
    Wang, Gin-Chung
    IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE, 2018, 6
  • [25] Prevalence and RIsk factors for Silent Myocardial ischemia (PRISM): A clinico observational study in patients of type 2 diabetes
    Prasad, D. S.
    Kabir, Zubair
    Devi, K. Revathi
    Peter, Pearline Suganthy
    Das, B. C.
    INDIAN HEART JOURNAL, 2019, 71 (05) : 400 - 405
  • [26] Intensive glycemic control in type 2 diabetics at high cardiovascular risk: do the benefits justify the risks?
    Shurraw, Sabin
    Tonelli, Marcello
    KIDNEY INTERNATIONAL, 2013, 83 (03) : 346 - 348
  • [27] Myocardial Ischemia in Type 2 Diabetic Patients
    Tlohi, Imane
    Karim, Fatiha
    Elamraoui, Asmae
    Choukrani, Hanane
    Habbal, Rachida
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S15 - S16
  • [28] Silent myocardial ischemia in patients with diabetes mellitus type 2
    Koshlia, V. I.
    Martynenko, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2015, (06) : 88 - 92
  • [29] Myocardial ischemia: a silent epidemic in Type 2 diabetes patients
    Le Feuvre, Claude
    Jacqueminet, Sophie
    Barthelemy, Olivier
    FUTURE CARDIOLOGY, 2011, 7 (02) : 183 - 190
  • [30] Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors
    Fornengo, P.
    Bosio, A.
    Epifani, G.
    Pallisco, O.
    Mancuso, A.
    Pascale, C.
    DIABETIC MEDICINE, 2006, 23 (07) : 775 - 779